# BEXAROTENE
> **ANDA210105** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS NY · Approved 2018-09-04
## Drug
- **FDA Application Number:** ANDA210105
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BEXAROTENE
- **Generic name:** BEXAROTENE
- **Active ingredients:** BEXAROTENE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL PHARMS NY
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2018-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210105)
---
*AI Analytics · CC0 1.0*